hVIVO plc (AIM:HVO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
7.90
-0.40 (-4.82%)
Mar 9, 2026, 4:36 PM GMT

hVIVO Revenue

hVIVO had revenue of 25.45M GBP in the half year ending June 30, 2025, a decrease of -11.18%. This brings the company's revenue in the last twelve months to 54.47M, down -18.96% year-over-year. In the year 2024, hVIVO had annual revenue of 66.22M with 12.87% growth.

Revenue (ttm)
54.47M
Revenue Growth
-18.96%
P/S Ratio
1.04
Revenue / Employee
180.96K
Employees
301
Market Cap
56.47M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202466.22M7.55M12.87%
Dec 31, 202358.67M7.97M15.72%
Dec 31, 202250.70M11.69M29.98%
Dec 31, 202139.01M17.06M77.76%
Dec 31, 202021.94M18.57M550.71%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ondine Biomedical 1.18M
Faron Pharmaceuticals Oy 1.14M
Bioventix 13.12M
4basebio 1.78M
ImmuPharma -69.96K
SkinBioTherapeutics 4.64M
Arecor Therapeutics 5.06M
Aptamer Group 1.20M
Revenue Rankings